Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines

Niels BilenbergChild and Adolescent Psychiatric Department, University of Southern Denmark

Christopher GillbergGothenburg Unit for Child and Adolescent Psychiatry, University of Gothenburg, Sweden

Tine HoumannCenter for Child and Adoelscent Psychiatry Glostrup, Capital Region Psychiatry, Faculty of Health Sciences, University of Copenhagen, Denmark

Bjørn KadesjøGothenburg Unit for Child and Adolescent Psychiatry, University of Gothenburg, Sweden

Michael B. LensingRegional Resource Center for Autism, ADHD, Tourette Syndrome and Narcolepsy, Oslo University Hospital, Norway

Kerstin J. PlessenCenter for Child and Adoelscent Psychiatry Bispebjerg, Capital Region Psychiatry, Faculty of Health Sciences, University of Copenhagen, DenmarkCorrespondence[email protected]

Gerd StrandNorwegian Resource Center for ADHD, Tourette Syndrome and Narcolepsy, Oslo University Hospital, Norway

Per Hove ThomsenCenter for Child and Adolescent Psychiatry Risskov, University of Århus, Denmark

Anne WorningDanish Association for people with ADHD

show all

"Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines." Nordic Journal of Psychiatry, 66(1), pp. 70–71

Declaration of interest: NielsBilenberg has given lectures for Janssen Cilag, Novartis, Medice, Eli Lilly. His research has been funded by LundbeckFonden.

Tine Houman has been speaker at symposiums sponsored by: Novartis Neuroscience, Eli Lilly, Janssen Cilag, Medice.

Per Hove Thomsen has given lectures and been chairman at symposia arranged by Novartis Healthcare and HB-Pharma and is a member of an advisory board in Denmark for Eli Lilly.

Christopher Gillberg has worked as a consultant for Eli Lilly and Jansen Cilag in the past.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines

Information for

Open access

Opportunities

Help and information

Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature